Literature DB >> 11836299

Role of calpain-10 gene variants in familial type 2 diabetes in Caucasians.

Steven C Elbein1, Winston Chu, Qianfang Ren, Chris Hemphill, John Schay, Nancy J Cox, Craig L Hanis, Sandra J Hasstedt.   

Abstract

The calpain-10 gene (CAPN10) has been implicated in type 2 diabetes (T2DM) susceptibility by both linkage and association in a Hispanic population from Starr County Texas. Common intronic variants seem to alter CAPN10 mRNA levels and were associated with insulin resistance but not diabetes in Pima Indians. The role of these variants in Caucasian populations is less clear. We found some evidence for linkage of T2DM to chromosome 2q approximately 20 cM proximal to the NIDDM1/CAPN10 locus. To test the hypothesis that CAPN10 is a diabetes susceptibility locus in Caucasian families at high risk for T2DM, we examined the influence of the three previously implicated CAPN10 variants on both diabetes risk and measures of insulin sensitivity and glucose homeostasis. We genotyped approximately 700 members of 63 families for 3 variants (SNP-43, SNP-19, and SNP-63). We tested each variant separately and as haplotype combinations for altered transmission from parents to affected children (transmission disequilibrium test), and we tested for an effect of each variant individually on measures of glucose and insulin during a glucose tolerance test in nondiabetic family members. Finally, we looked for an effect of each variant on measures of insulin sensitivity (S(I)) and insulin secretion estimated by frequently sampled iv glucose tolerance test and Minimal Model analysis. We could not confirm an increase in risk for T2DM susceptibility for any variant or for any haplotype combination, although we found marginal evidence for an increased risk of the 111/221 haplotype combination (P = 0.036) after ascertainment correction. However, both SNP-19 and SNP-63 increased fasting and/or postchallenge insulin levels, consistent with reduced insulin sensitivity. Furthermore, SNP-19 had modest effects on insulin sensitivity measured by homeostatic model, and on postchallenge glucose. The reduction in insulin sensitivity was confirmed by analysis of the subset of individuals who underwent iv glucose tolerance tests, where SNP-19 significantly altered the insulin sensitivity index. CAPN10 cannot be considered a major diabetes susceptibility gene in our population and seems unlikely to explain the observed linkage findings. However, CAPN10 influences insulin sensitivity and glucose homeostasis in nondiabetic members of kindreds at high risk for T2DM.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11836299     DOI: 10.1210/jcem.87.2.8210

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  20 in total

1.  Meta-analysis and a large association study confirm a role for calpain-10 variation in type 2 diabetes susceptibility.

Authors:  Michael N Weedon; Peter E H Schwarz; Yukio Horikawa; Naoko Iwasaki; Thomas Illig; Rolf Holle; Wolfgang Rathmann; Thomas Selisko; Jan Schulze; Katherine R Owen; Julie Evans; Laura Del Bosque-Plata; Graham Hitman; Mark Walker; Jonathan C Levy; Mike Sampson; Graeme I Bell; Mark I McCarthy; Andrew T Hattersley; Timothy M Frayling
Journal:  Am J Hum Genet       Date:  2003-11       Impact factor: 11.025

Review 2.  Genetics of diabetes.

Authors:  Richard B Horenstein; Alan R Shuldiner
Journal:  Rev Endocr Metab Disord       Date:  2004-03       Impact factor: 6.514

3.  Common polymorphisms of calpain-10 are associated with abdominal obesity in subjects at high risk of type 2 diabetes.

Authors:  J Pihlajamäki; U Salmenniemi; M Vänttinen; E Ruotsalainen; J Kuusisto; I Vauhkonen; S Kainulainen; M C Y Ng; N J Cox; G I Bell; M Laakso
Journal:  Diabetologia       Date:  2006-05-12       Impact factor: 10.122

4.  The Genetic Basis of Type 2 Diabetes.

Authors:  Swapan Kumar Das; Steven C Elbein
Journal:  Cellscience       Date:  2006-04-30

5.  A novel 111/121 diplotype in the Calpain-10 gene is associated with type 2 diabetes.

Authors:  Eun Seok Kang; Hye Joo Kim; Moonsuk Nam; Chung Mo Nam; Chul Woo Ahn; Bong Soo Cha; Hyun Chul Lee
Journal:  J Hum Genet       Date:  2006-05-24       Impact factor: 3.172

Review 6.  Pharmacogenetics of posttransplant diabetes mellitus.

Authors:  P Lancia; T Adam de Beaumais; E Jacqz-Aigrain
Journal:  Pharmacogenomics J       Date:  2017-03-28       Impact factor: 3.550

Review 7.  Calpain 10 and genetics of type 2 diabetes.

Authors:  Nancy J Cox
Journal:  Curr Diab Rep       Date:  2002-04       Impact factor: 4.810

8.  Common polymorphisms of calpain-10 and the risk of Type 2 Diabetes in a Tunisian Arab population: a case-control study.

Authors:  Intissar Ezzidi; Amira Turki; Safia Messaoudi; Molka Chaieb; Maha Kacem; Ghada M Al-Khateeb; Touhami Mahjoub; Wassim Y Almawi; Nabil Mtiraoui
Journal:  BMC Med Genet       Date:  2010-05-15       Impact factor: 2.103

Review 9.  Genetics of the polycystic ovary syndrome.

Authors:  Gülüm Kosova; Margrit Urbanek
Journal:  Mol Cell Endocrinol       Date:  2012-10-16       Impact factor: 4.102

10.  Are variants in the CAPN10 gene related to risk of type 2 diabetes? A quantitative assessment of population and family-based association studies.

Authors:  Yiqing Song; Tianhua Niu; JoAnn E Manson; David J Kwiatkowski; Simin Liu
Journal:  Am J Hum Genet       Date:  2004-01-13       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.